Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case–control study

Journal of the Royal Society of Medicine(2023)10.1177/01410768231214341Source: DataRank Database

ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case–control study is a research paper published in Journal of the Royal Society of Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.55)OA: hybridTopics (25)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (93)

Pankaj Sharma ORCID,on behalf of the international Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis (BEAST) collaborators and Cerebral Venous Sinus Thrombosis With Thrombocytopenia Syndrome Study Group,Anita van de Munckhof ORCID,Katarzyna Krzywicka ORCID,Mayte Sánchez van Kammen ORCID

Live enrichment

PubMed:38086410 PMC:PMC10949869 OpenAlex:https://openalex.org/W4389640072

National Institutes of Health

Grant: U01NS069208

Swedish Heart and Lung Foundation

Grant: 20190203

Swedish Research Council

Grant: 2018-02543

NINDS NIH HHS

Grant: R01 NS100178

NINDS NIH HHS

Grant: R01 NS105150

FWCI

0.55

Citation Percentile

0.7%

Citation Trend

2024

2025

hybridLicense: cc-by

journalhttps://journals.sagepub.com/doi/pdf/10.1177/01410768231214341

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/01410768231214341

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/01410768231214341

journalhttps://doi.org/10.1177/01410768231214341

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38086410

Fields of Study

Blood groups and transfusionHeparin-Induced Thrombocytopenia and ThrombosisCerebral Venous Sinus Thrombosis

MeSH Terms

ABO Blood-Group SystemCOVID-19COVID-19 VaccinesAdolescentHumansThrombocytopeniaVaccinationCase-Control StudiesVenous Thrombosis

Keywords

MedicineABO blood group systemVaccinationThrombosisBlood type (non-human)Internal medicineVenous thrombosisSurgeryImmunologyCerebral Venous ThrombosisBlood GroupOxford-AstrazenecaChadox1-s Covid-19 Vaccine

Sustainable Development Goals

SDG 0: Good health and well-being